Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Growing SharePoint User Frustration Spurs SureClinical to Release White Paper for BioPharma Companies, ‘Evaluating SharePoint-Based eTMF Applications’
  • USA - English


News provided by

SureClinical

Jan 27, 2014, 13:50 ET

Share this article

Share toX

Share this article

Share toX

Rancho Cordova, CA (PRWEB) January 27, 2014 -- SureClinical announced today the publication of their newest white paper, “Evaluating SharePoint-based eTMF applications.” The white paper provides a comparison of SharePoint-based eTMF applications and collaborative cloud portals with integrated multi-organization digital signing capabilities.

Nearly fifteen years after the first introduction of SharePoint, SharePoint user surveys and articles are increasingly negative toward the usability and actual user adoption of SharePoint-based solutions. In addition to an inflexible, proprietary and outdated architecture, SharePoint’s most cited customer complaints target its user interface, limited functionality, costly and time consuming software maintenance, support and integration issues. Microsoft itself makes no claims that SharePoint is FDA 21 CFR Part 11 compliant, in the cloud or on-premises. As a result of SharePoint’s inability to meet user needs as well as a lack of support for FDA Part 11 regulations, BioPharma should be fully aware of the potential usability, compliance and security issues when considering SharePoint as an application platform in clinical trials.

Forrester Survey Shows Majority of Users Don’t Like SharePoint and are Not Adopting It

A recent Forrester Research survey report found that SharePoint is struggling to transition customers to its new cloud architecture. Because the SharePoint platform is often distributed for free by Microsoft with Microsoft Servers, it’s widely pervasive in enterprises. However, despite its widespread distribution, SharePoint users are expressing growing frustration. Noted market research firm Forrester Research conducted a SharePoint 2013 user survey and reported that an overwhelming majority of customers struggle with SharePoint’s Cloud and Mobile capabilities and 64% of organizations are not seeing the level of adoption expected, while 62% of users surveyed don’t like the SharePoint experience.

Widespread User Dissatisfaction Drives Users to Seek SharePoint Antidote

As SharePoint 2013 appears to be entering its twilight, user’s frustration with the platform has reached a critical level. According to Huffington Post, SharePoint users feel a ‘deep-seated disgust’ for SharePoint. In recent articles, popular media outlets ZDNet, PCWorld, CIO World, ZDNet, AIIM and more question SharePoint’s future, especially its ability to transition from an on-premises software application to a collaborative cloud application platform for use by organization collaboration beyond the corporate firewall. Due to its frustrating user interface and lack of features, users often secretly revert back to email for file sharing and collaboration, says Nick Gamiano in a July 2013 posting at Huddle.com.

“SharePoint user surveys point to an aging architecture that no longer meets enterprise user needs,” said Zachariah Schmidt, CEO of SureClinical and author of the white paper, ‘Evaluating SharePoint-based eTMF Applications.’ “While Microsoft has some excellent office applications, as far as SharePoint goes it’s time for organizations to retire SharePoint as a platform for clinical trial applications and to move up to the next generation of content management for health sciences: collaborative cloud solutions that run on an easy to use, flexible, standards-based architecture that’s FDA Part 11 and HIPAA compliant.”

SureTrial eTMF Collaborative Cloud Platform with Mobile Digital Signing – The SharePoint Antidote

In contrast to SharePoint’s aging architecture and inability to seamlessly enable cloud collaboration, SureClinical’s SureTrial eTMF collaborative cloud platform provides clinical trial organizations with immediate time to value. With SureTrial’s advanced architectures, technology standard support, paperless clinical trial study enrollment, all running in cloud-based FDA 21 CFR Part 11 solution, BioPharma organizations can streamline clinical trial operations and accelerate time to market.

SureEsign – Cloud-based Mobile Digital Signing Technology

As the only eTMF solution to provide paperless content completion in the cloud for organizations outside the corporate firewall, sponsors and CRO’s can enroll investigators in studies through the SureEsign mobile web client and SurePortal. Incorporating a simple to use PDF document viewer with patent-pending integrated digital signing with multi-factor authentication, SureClinical’s SureEsign mobile web client is almost like having a pocketable digital notary. It runs on most smartphones and enables verifiable digital document signing and content completion at the point of origin, providing paperless content completion and collaboration across clinical research organizations, sponsors, investigators and clinical trial stakeholders. Per FDA Part 11 requirements, all digital signing transactions are tracked in a non-modifiable audit trail. The SureEsign solution is the only digital content signing solution for health sciences that works beyond the corporate firewall on mobile web devices, enabling clinical trial study investigator enrollment in days, not weeks.

Sources

ZDNet, “SharePoint: Can it navigate the cloud, mobile curves ahead?”,
http://www.zdnet.com/sharepoint-can-it-navigate-the-cloud-mobile-curves-ahead-7000022162/

PCWorld, “Microsoft SharePoint faces a challenging future: Forrester,” Feb 2013,
http://www.pcworld.com/article/2027391/microsoft-sharepoint-faces-a-challenging-future-forrester.html

CiteWorld, “How did SharePoint become the poster child for bad enterprise software?,” Jan 2013
http://www.citeworld.com/social/21352/how-did-sharepoint-become-product-everybody-loves-bash?page=0

CIO Insight, “The Problems With Microsoft SharePoint,” March 2013,
http://www.cioinsight.com/it-strategy/messaging-collaboration/slideshows/the-problems-with-microsoft-sharepoint-14

Forrester Research, "SharePoint Enters Its Awkward Teenage Years", October 2013, http://www.forrester.com/SharePoint+Enters+Its+Awkward+Teenage+Years/fulltext/-/E-RES89021

About SureClinical
SureClinical provides cloud-based health science applications that automate business processes and eliminate paper. SureClinical’s Certified Cloud includes integrated document completion, Esigning and archiving for networks of health science organizations that wish to share documents in an automated, regulated cloud environment. SureClinical's applications run on Android®, Apple® iPad, Apple® IOS, and other popular smartphone platforms, as well as on all major web browsers. For more information, visit http://www.SureClinical.com.

Copyright © 2014 SureClinical. All rights reserved. SureClinical, SureEsign, SureTrial, Certified Cloud, SurePortal and the SureTrial logo are trademarks of SureClinical. Other names used herein may be trademarks of their respective owners.

Zack Schmidt, SureClinical, http://www.sureclinical.com, 916-265-2000, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.